Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

November 1, 2023; Volume 64,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abdelhafez, Yasser

    1. Total-Body Perfusion Imaging with [<sup>11</sup>C]-Butanol
      You have access
      Total-Body Perfusion Imaging with [11C]-Butanol
      Elizabeth J. Li, Javier E. López, Benjamin A. Spencer, Yasser Abdelhafez, Ramsey D. Badawi, Guobao Wang and Simon R. Cherry
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1831-1838; DOI: https://doi.org/10.2967/jnumed.123.265659
  2. Abdelhafez, Yasser G.

    1. Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Open Access
      Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1821-1830; DOI: https://doi.org/10.2967/jnumed.123.265723
  3. Abramson, Vandana G.

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  4. af Burén, Siri

    1. You have access
      HER2-Low Breast Cancer Can Be Visualized by HER2 PET
      Renske Altena, Siri af Burén, Thuy Tran and Rimma Axelsson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1841; DOI: https://doi.org/10.2967/jnumed.123.266101
  5. Aizenstein, Howard

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  6. Al-Hallak, Najeeb

    1. Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      You have access
      Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      Farzaneh Rezazadeh, Nicholas Ramos, Allen-Dexter Saliganan, Najeeb Al-Hallak, Kang Chen, Bashar Mohamad, Wendy N. Wiesend and Nerissa T. Viola
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1806-1814; DOI: https://doi.org/10.2967/jnumed.123.265649
  7. Alberto, Signore

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  8. Alipour, Ramin

    1. You have access
      Out with the Old, in with the New: Can We Bridge the Gap Between Clinical Trial Results Based on Bone Scans and the Era of Modern Prostate Cancer Imaging?
      Michal Eifer, Ramin Alipour, Michael S. Hofman and Aravind S. Ravi Kumar
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1748-1749; DOI: https://doi.org/10.2967/jnumed.123.266025
  9. Allen-Auerbach, Martin

    1. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      You have access
      Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1744-1747; DOI: https://doi.org/10.2967/jnumed.123.265916
  10. Altena, Renske

    1. You have access
      HER2-Low Breast Cancer Can Be Visualized by HER2 PET
      Renske Altena, Siri af Burén, Thuy Tran and Rimma Axelsson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1841; DOI: https://doi.org/10.2967/jnumed.123.266101
  11. Andl, George

    1. Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      You have access
      Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      Milan Grkovski, Joseph A. O’Donoghue, Brandon S. Imber, George Andl, Cheng Tu, Daniel Lafontaine, Jazmin Schwartz, Maria Thor, Michael J. Zelefsky, John L. Humm and Lisa Bodei
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1779-1787; DOI: https://doi.org/10.2967/jnumed.123.265763
  12. Appiah, Jean-Pierre K.

    1. Optimized Methods for the Production of High-Purity <sup>203</sup>Pb Using Electroplated Thallium Targets
      You have access
      Optimized Methods for the Production of High-Purity 203Pb Using Electroplated Thallium Targets
      Shefali Saini, Jennifer L. Bartels, Jean-Pierre K. Appiah, Jason H. Rider, Nicholas Baumhover, Michael K. Schultz and Suzanne E. Lapi
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1791-1797; DOI: https://doi.org/10.2967/jnumed.123.265976
  13. Arjun, Chanda

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  14. Atzinger, Armin

    1. You have access
      FAPI PET/CT Immune-Fibrosis Imaging for New Insights into Rheumatologic Disorders
      Christian Schmidkonz, Armin Atzinger, Andreas Ramming and Torsten Kuwert
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1674-1675; DOI: https://doi.org/10.2967/jnumed.123.266182
  15. Aulakh, Gurpreet Kaur

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  16. Axelsson, Rimma

    1. You have access
      HER2-Low Breast Cancer Can Be Visualized by HER2 PET
      Renske Altena, Siri af Burén, Thuy Tran and Rimma Axelsson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1841; DOI: https://doi.org/10.2967/jnumed.123.266101

B

  1. Badawi, Ramsey D.

    1. Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Open Access
      Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1821-1830; DOI: https://doi.org/10.2967/jnumed.123.265723
    2. Total-Body Perfusion Imaging with [<sup>11</sup>C]-Butanol
      You have access
      Total-Body Perfusion Imaging with [11C]-Butanol
      Elizabeth J. Li, Javier E. López, Benjamin A. Spencer, Yasser Abdelhafez, Ramsey D. Badawi, Guobao Wang and Simon R. Cherry
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1831-1838; DOI: https://doi.org/10.2967/jnumed.123.265659
  2. Bando-Delaunay, Aurélie

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  3. Barata, Pedro

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  4. Barbato, Francesco

    1. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      You have access
      Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1744-1747; DOI: https://doi.org/10.2967/jnumed.123.265916
  5. Bartels, Jennifer L.

    1. Optimized Methods for the Production of High-Purity <sup>203</sup>Pb Using Electroplated Thallium Targets
      You have access
      Optimized Methods for the Production of High-Purity 203Pb Using Electroplated Thallium Targets
      Shefali Saini, Jennifer L. Bartels, Jean-Pierre K. Appiah, Jason H. Rider, Nicholas Baumhover, Michael K. Schultz and Suzanne E. Lapi
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1791-1797; DOI: https://doi.org/10.2967/jnumed.123.265976
  6. Baumhover, Nicholas

    1. Optimized Methods for the Production of High-Purity <sup>203</sup>Pb Using Electroplated Thallium Targets
      You have access
      Optimized Methods for the Production of High-Purity 203Pb Using Electroplated Thallium Targets
      Shefali Saini, Jennifer L. Bartels, Jean-Pierre K. Appiah, Jason H. Rider, Nicholas Baumhover, Michael K. Schultz and Suzanne E. Lapi
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1791-1797; DOI: https://doi.org/10.2967/jnumed.123.265976
  7. Benz, Matthias

    1. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      You have access
      Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1744-1747; DOI: https://doi.org/10.2967/jnumed.123.265916
  8. Berriolo-Riedinger, Alina

    1. Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      You have access
      Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas and Caroline Bodet-Milin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1706-1711; DOI: https://doi.org/10.2967/jnumed.123.265871
  9. Beziere, Nicolas

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  10. Blanc-Durand, Paul

    1. Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      You have access
      Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas and Caroline Bodet-Milin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1706-1711; DOI: https://doi.org/10.2967/jnumed.123.265871
  11. Bodei, Lisa

    1. Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      You have access
      Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      Milan Grkovski, Joseph A. O’Donoghue, Brandon S. Imber, George Andl, Cheng Tu, Daniel Lafontaine, Jazmin Schwartz, Maria Thor, Michael J. Zelefsky, John L. Humm and Lisa Bodei
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1779-1787; DOI: https://doi.org/10.2967/jnumed.123.265763
  12. Bodet-Milin, Caroline

    1. Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      You have access
      Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas and Caroline Bodet-Milin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1706-1711; DOI: https://doi.org/10.2967/jnumed.123.265871
  13. Boellaard, Ronald

    1. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab
      You have access
      Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab
      Philipp Mohr, Joyce van Sluis, Laura Providência, Johannes H. van Snick, Marjolijn N. Lub-de Hooge, Antoon T. Willemsen, Andor W.J.M. Glaudemans, Ronald Boellaard, Adriaan A. Lammertsma, Adrienne H. Brouwers and Charalampos Tsoumpas
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1815-1820; DOI: https://doi.org/10.2967/jnumed.123.265621
  14. Bourgeat, Pierrick

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  15. Brenner, Winfried

    1. Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using <sup>18</sup>F-FET PET
      Open Access
      Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18F-FET PET
      Johannes Lohmeier, Helena Radbruch, Winfried Brenner, Bernd Hamm, Anna Tietze and Marcus R. Makowski
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1683-1689; DOI: https://doi.org/10.2967/jnumed.123.265642
  16. Brouwers, Adrienne H.

    1. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab
      You have access
      Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab
      Philipp Mohr, Joyce van Sluis, Laura Providência, Johannes H. van Snick, Marjolijn N. Lub-de Hooge, Antoon T. Willemsen, Andor W.J.M. Glaudemans, Ronald Boellaard, Adriaan A. Lammertsma, Adrienne H. Brouwers and Charalampos Tsoumpas
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1815-1820; DOI: https://doi.org/10.2967/jnumed.123.265621

C

  1. Cadiot, Guillaume

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  2. Calais, Jeremie

    1. Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      You have access
      Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1737-1743; DOI: https://doi.org/10.2967/jnumed.122.265155
    2. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
    3. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      You have access
      Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1744-1747; DOI: https://doi.org/10.2967/jnumed.123.265916
    4. Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Open Access
      Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Catherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik and Magnus Dahlbom
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1772-1778; DOI: https://doi.org/10.2967/jnumed.123.265433
    5. You have access
      Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [68Ga]Ga-FAPI-46 PET–Positive and [18F]FDG PET–Negative
      Peter George Maliha, Abie H. Mendelsohn, Johannes Czernin, Taylor Howard, Jeremie Calais and Masatoshi Hotta
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1839-1840; DOI: https://doi.org/10.2967/jnumed.123.265498
  3. Carey, Lisa A.

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  4. Casasnovas, René-Olivier

    1. Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      You have access
      Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas and Caroline Bodet-Milin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1706-1711; DOI: https://doi.org/10.2967/jnumed.123.265871
  5. Chaudhari, Abhijit J.

    1. Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Open Access
      Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1821-1830; DOI: https://doi.org/10.2967/jnumed.123.265723
  6. Chen, Kang

    1. Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      You have access
      Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      Farzaneh Rezazadeh, Nicholas Ramos, Allen-Dexter Saliganan, Najeeb Al-Hallak, Kang Chen, Bashar Mohamad, Wendy N. Wiesend and Nerissa T. Viola
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1806-1814; DOI: https://doi.org/10.2967/jnumed.123.265649
  7. Cherry, Simon R.

    1. Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Open Access
      Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1821-1830; DOI: https://doi.org/10.2967/jnumed.123.265723
    2. Total-Body Perfusion Imaging with [<sup>11</sup>C]-Butanol
      You have access
      Total-Body Perfusion Imaging with [11C]-Butanol
      Elizabeth J. Li, Javier E. López, Benjamin A. Spencer, Yasser Abdelhafez, Ramsey D. Badawi, Guobao Wang and Simon R. Cherry
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1831-1838; DOI: https://doi.org/10.2967/jnumed.123.265659
  8. Choyke, Peter L.

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  9. Cimino-Mathews, Ashley

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  10. Cohen, Ann D.

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  11. Connolly, Roisin M.

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  12. Cornelissen, Bart

    1. You have access
      Second Symposium of the European Working Group on the Radiobiology of Molecular Radionuclide Therapy
      Julie Nonnekens, Bart Cornelissen and Samantha Y.A. Terry; on behalf of the European Working Group on the Radiobiology of Molecular Radiotherapy
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1788-1790; DOI: https://doi.org/10.2967/jnumed.123.265956
  13. Cros, Jérôme

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  14. Cuevas, Clara L. Santos

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  15. Czernin, Johannes

    1. Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      You have access
      Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1737-1743; DOI: https://doi.org/10.2967/jnumed.122.265155
    2. Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Open Access
      Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Catherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik and Magnus Dahlbom
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1772-1778; DOI: https://doi.org/10.2967/jnumed.123.265433
    3. You have access
      Advancing Nuclear Medicine at the Multiomics Intersection
      Kalevi Kairemo and Johannes Czernin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1671-1673; DOI: https://doi.org/10.2967/jnumed.123.266793
    4. You have access
      Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [68Ga]Ga-FAPI-46 PET–Positive and [18F]FDG PET–Negative
      Peter George Maliha, Abie H. Mendelsohn, Johannes Czernin, Taylor Howard, Jeremie Calais and Masatoshi Hotta
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1839-1840; DOI: https://doi.org/10.2967/jnumed.123.265498

D

  1. D’Alessandria, Calogero

    1. Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&amp;T
      You have access
      Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
      Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
  2. Dadachova, Ekaterina

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  3. Dahlbom, Magnus

    1. Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Open Access
      Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Catherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik and Magnus Dahlbom
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1772-1778; DOI: https://doi.org/10.2967/jnumed.123.265433
  4. Das, Chandan Krushna

    1. [<sup>177</sup>Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      You have access
      [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Chandan Krushna Das, Ravimohan Suryanarayan Mavuduru, Shikha Goyal, Jaya Shukla and Shrawan Kumar Singh
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1726-1729; DOI: https://doi.org/10.2967/jnumed.123.266141
  5. Debus, Juergen

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  6. de Mestier, Louis

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  7. Denbow, Rita

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  8. De Rycke, Ophélie

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  9. Doré, Vincent

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  10. Drakaki, Alexandra

    1. Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      You have access
      Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1737-1743; DOI: https://doi.org/10.2967/jnumed.122.265155
  11. Drzezga, Alexander

    1. Prediction of Response to <sup>177</sup>Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC
      You have access
      Prediction of Response to 177Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC
      Melanie Hohberg, Manuel Reifegerst, Alexander Drzezga, Markus Wild and Matthias Schmidt
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1758-1764; DOI: https://doi.org/10.2967/jnumed.122.264953

E

  1. Ebenhan, Thomas

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  2. Eiber, Matthias

    1. Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&amp;T
      You have access
      Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
      Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
  3. Eifer, Michal

    1. You have access
      Out with the Old, in with the New: Can We Bridge the Gap Between Clinical Trial Results Based on Bone Scans and the Era of Modern Prostate Cancer Imaging?
      Michal Eifer, Ramin Alipour, Michael S. Hofman and Aravind S. Ravi Kumar
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1748-1749; DOI: https://doi.org/10.2967/jnumed.123.266025
  4. Einspieler, Holger

    1. Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980

F

  1. Fendler, Wolfgang P.

    1. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      You have access
      Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1744-1747; DOI: https://doi.org/10.2967/jnumed.123.265916
  2. Feuerecker, Benedikt

    1. Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&amp;T
      You have access
      Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
      Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
  3. Fink, Christoph

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046

G

  1. Gafita, Andrei

    1. Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      You have access
      Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1737-1743; DOI: https://doi.org/10.2967/jnumed.122.265155
  2. Gao, Jie

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  3. Gat, Elodie

    1. Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      You have access
      Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas and Caroline Bodet-Milin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1706-1711; DOI: https://doi.org/10.2967/jnumed.123.265871
  4. Gebhart, Geraldine

    1. You have access
      18F-FDG PET “Metabolic Response” to Neoadjuvant Systemic Therapy for Breast Cancer: Quo Vadis?
      Geraldine Gebhart
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1697-1698; DOI: https://doi.org/10.2967/jnumed.123.266303
  5. Giesel, Frederik L.

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  6. Glaudemans, Andor W.J.M.

    1. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab
      You have access
      Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab
      Philipp Mohr, Joyce van Sluis, Laura Providência, Johannes H. van Snick, Marjolijn N. Lub-de Hooge, Antoon T. Willemsen, Andor W.J.M. Glaudemans, Ronald Boellaard, Adriaan A. Lammertsma, Adrienne H. Brouwers and Charalampos Tsoumpas
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1815-1820; DOI: https://doi.org/10.2967/jnumed.123.265621
  7. Gogola, Alexandra

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  8. Goichot, Bernard

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  9. Gouill, Steven Le

    1. Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      You have access
      Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas and Caroline Bodet-Milin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1706-1711; DOI: https://doi.org/10.2967/jnumed.123.265871
  10. Goyal, Shikha

    1. [<sup>177</sup>Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      You have access
      [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Chandan Krushna Das, Ravimohan Suryanarayan Mavuduru, Shikha Goyal, Jaya Shukla and Shrawan Kumar Singh
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1726-1729; DOI: https://doi.org/10.2967/jnumed.123.266141
  11. Granados, Ulises

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  12. Grkovski, Milan

    1. Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      You have access
      Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      Milan Grkovski, Joseph A. O’Donoghue, Brandon S. Imber, George Andl, Cheng Tu, Daniel Lafontaine, Jazmin Schwartz, Maria Thor, Michael J. Zelefsky, John L. Humm and Lisa Bodei
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1779-1787; DOI: https://doi.org/10.2967/jnumed.123.265763
  13. Grogan, Tristan

    1. Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      You have access
      Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1737-1743; DOI: https://doi.org/10.2967/jnumed.122.265155
  14. Grubmüller, Bernhard

    1. Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980
  15. Guo, Hongqian

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  16. Guo, Shikuan

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  17. Gupta, Pawan

    1. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      You have access
      Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1744-1747; DOI: https://doi.org/10.2967/jnumed.123.265916
  18. Gutschmayer, Sebastian

    1. Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980

H

  1. Haberkorn, Uwe

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  2. Haberl, David

    1. Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980
  3. Hacker, Marcus

    1. Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980
  4. Hamm, Bernd

    1. Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using <sup>18</sup>F-FET PET
      Open Access
      Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18F-FET PET
      Johannes Lohmeier, Helena Radbruch, Winfried Brenner, Bernd Hamm, Anna Tietze and Marcus R. Makowski
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1683-1689; DOI: https://doi.org/10.2967/jnumed.123.265642
  5. Han, Donghui

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  6. Harris, Kendra

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  7. Haug, Alexander

    1. Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980
  8. Hawkins, Madeline

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  9. Heck, Matthias M.

    1. Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&amp;T
      You have access
      Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
      Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
  10. Hecker, Charlotte-Sophie

    1. Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&amp;T
      You have access
      Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
      Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
  11. Hennessy, Maeve A.

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  12. Hentic, Olivia

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  13. Herfarth, Klaus

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  14. Hernandez Pampaloni, Miguel

    1. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      You have access
      Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1744-1747; DOI: https://doi.org/10.2967/jnumed.123.265916
  15. Hofman, Michael S.

    1. You have access
      Out with the Old, in with the New: Can We Bridge the Gap Between Clinical Trial Results Based on Bone Scans and the Era of Modern Prostate Cancer Imaging?
      Michal Eifer, Ramin Alipour, Michael S. Hofman and Aravind S. Ravi Kumar
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1748-1749; DOI: https://doi.org/10.2967/jnumed.123.266025
  16. Hohberg, Melanie

    1. Prediction of Response to <sup>177</sup>Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC
      You have access
      Prediction of Response to 177Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC
      Melanie Hohberg, Manuel Reifegerst, Alexander Drzezga, Markus Wild and Matthias Schmidt
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1758-1764; DOI: https://doi.org/10.2967/jnumed.122.264953
  17. Hope, Thomas A.

    1. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      You have access
      Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1744-1747; DOI: https://doi.org/10.2967/jnumed.123.265916
  18. Hotta, Masatoshi

    1. You have access
      Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [68Ga]Ga-FAPI-46 PET–Positive and [18F]FDG PET–Negative
      Peter George Maliha, Abie H. Mendelsohn, Johannes Czernin, Taylor Howard, Jeremie Calais and Masatoshi Hotta
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1839-1840; DOI: https://doi.org/10.2967/jnumed.123.265498
  19. Howard, Taylor

    1. You have access
      Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [68Ga]Ga-FAPI-46 PET–Positive and [18F]FDG PET–Negative
      Peter George Maliha, Abie H. Mendelsohn, Johannes Czernin, Taylor Howard, Jeremie Calais and Masatoshi Hotta
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1839-1840; DOI: https://doi.org/10.2967/jnumed.123.265498
  20. Huang, Chiung-Yu

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  21. Huang, Minqui

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  22. Humm, John L.

    1. Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      You have access
      Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      Milan Grkovski, Joseph A. O’Donoghue, Brandon S. Imber, George Andl, Cheng Tu, Daniel Lafontaine, Jazmin Schwartz, Maria Thor, Michael J. Zelefsky, John L. Humm and Lisa Bodei
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1779-1787; DOI: https://doi.org/10.2967/jnumed.123.265763

I

  1. Ikonomovic, Milos D.

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  2. Imber, Brandon S.

    1. Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      You have access
      Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      Milan Grkovski, Joseph A. O’Donoghue, Brandon S. Imber, George Andl, Cheng Tu, Daniel Lafontaine, Jazmin Schwartz, Maria Thor, Michael J. Zelefsky, John L. Humm and Lisa Bodei
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1779-1787; DOI: https://doi.org/10.2967/jnumed.123.265763
  3. Imperiale, Alessio

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  4. Itti, Emmanuel

    1. Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      You have access
      Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas and Caroline Bodet-Milin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1706-1711; DOI: https://doi.org/10.2967/jnumed.123.265871

J

  1. Jaeger, Dirk

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  2. Jain, Sanjay K.

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  3. Jalilian, Amirreza

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  4. Jang, Albert

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  5. Jiang, Fei

    1. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      You have access
      Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1744-1747; DOI: https://doi.org/10.2967/jnumed.123.265916
  6. Jiao, Jianhua

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  7. Jing, Yuming

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  8. Jones, Terry

    1. Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Open Access
      Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1821-1830; DOI: https://doi.org/10.2967/jnumed.123.265723
  9. Juarez, Roxana

    1. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      You have access
      Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
      Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1744-1747; DOI: https://doi.org/10.2967/jnumed.123.265916

K

  1. Kairemo, Kalevi

    1. You have access
      Advancing Nuclear Medicine at the Multiomics Intersection
      Kalevi Kairemo and Johannes Czernin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1671-1673; DOI: https://doi.org/10.2967/jnumed.123.266793
  2. Kang, Fei

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  3. Kanoun, Salim

    1. Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      You have access
      Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas and Caroline Bodet-Milin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1706-1711; DOI: https://doi.org/10.2967/jnumed.123.265871
  4. Karimzadeh, Amir

    1. Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&amp;T
      You have access
      Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
      Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
  5. Kauczor, Hans-Ulrich

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  6. Kenner, Lukas

    1. Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980
  7. Kluge, Kilian

    1. Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980
  8. Klunk, William E.

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  9. Knorr, Karina

    1. Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&amp;T
      You have access
      Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
      Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
  10. Koerber, Stefan A.

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  11. Korde, Aruna

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  12. Kraeber-Bodéré, Françoise

    1. Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      You have access
      Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas and Caroline Bodet-Milin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1706-1711; DOI: https://doi.org/10.2967/jnumed.123.265871
  13. Kramer, Gero

    1. Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980
  14. Krop, Ian E.

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  15. Kumar, Aravind S. Ravi

    1. You have access
      Out with the Old, in with the New: Can We Bridge the Gap Between Clinical Trial Results Based on Bone Scans and the Era of Modern Prostate Cancer Imaging?
      Michal Eifer, Ramin Alipour, Michael S. Hofman and Aravind S. Ravi Kumar
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1748-1749; DOI: https://doi.org/10.2967/jnumed.123.266025
  16. Kuwert, Torsten

    1. You have access
      FAPI PET/CT Immune-Fibrosis Imaging for New Insights into Rheumatologic Disorders
      Christian Schmidkonz, Armin Atzinger, Andreas Ramming and Torsten Kuwert
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1674-1675; DOI: https://doi.org/10.2967/jnumed.123.266182

L

  1. Lachachi, Choaib

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  2. Lafontaine, Daniel

    1. Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      You have access
      Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      Milan Grkovski, Joseph A. O’Donoghue, Brandon S. Imber, George Andl, Cheng Tu, Daniel Lafontaine, Jazmin Schwartz, Maria Thor, Michael J. Zelefsky, John L. Humm and Lisa Bodei
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1779-1787; DOI: https://doi.org/10.2967/jnumed.123.265763
  3. Lammertsma, Adriaan A.

    1. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab
      You have access
      Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab
      Philipp Mohr, Joyce van Sluis, Laura Providência, Johannes H. van Snick, Marjolijn N. Lub-de Hooge, Antoon T. Willemsen, Andor W.J.M. Glaudemans, Ronald Boellaard, Adriaan A. Lammertsma, Adrienne H. Brouwers and Charalampos Tsoumpas
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1815-1820; DOI: https://doi.org/10.2967/jnumed.123.265621
  4. Lanka, Sree

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  5. Lapi, Suzanne E.

    1. Optimized Methods for the Production of High-Purity <sup>203</sup>Pb Using Electroplated Thallium Targets
      You have access
      Optimized Methods for the Production of High-Purity 203Pb Using Electroplated Thallium Targets
      Shefali Saini, Jennifer L. Bartels, Jean-Pierre K. Appiah, Jason H. Rider, Nicholas Baumhover, Michael K. Schultz and Suzanne E. Lapi
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1791-1797; DOI: https://doi.org/10.2967/jnumed.123.265976
  6. Layton, Jodi

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  7. Leal, Jeffrey P.

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  8. Lebtahi, Rachida

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  9. Ledet, Elisa

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  10. Lestari, Wening

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  11. Lewis, Brian

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  12. Li, Elizabeth J.

    1. Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Open Access
      Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1821-1830; DOI: https://doi.org/10.2967/jnumed.123.265723
    2. Total-Body Perfusion Imaging with [<sup>11</sup>C]-Butanol
      You have access
      Total-Body Perfusion Imaging with [11C]-Butanol
      Elizabeth J. Li, Javier E. López, Benjamin A. Spencer, Yasser Abdelhafez, Ramsey D. Badawi, Guobao Wang and Simon R. Cherry
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1831-1838; DOI: https://doi.org/10.2967/jnumed.123.265659
  13. Li, Yu

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  14. Li, Zeyu

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  15. Lieberman, Alex

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  16. Liermann, Jakob

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  17. Liu, Minetta C.

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  18. Lohmeier, Johannes

    1. Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using <sup>18</sup>F-FET PET
      Open Access
      Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18F-FET PET
      Johannes Lohmeier, Helena Radbruch, Winfried Brenner, Bernd Hamm, Anna Tietze and Marcus R. Makowski
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1683-1689; DOI: https://doi.org/10.2967/jnumed.123.265642
  19. López, Javier E.

    1. Total-Body Perfusion Imaging with [<sup>11</sup>C]-Butanol
      You have access
      Total-Body Perfusion Imaging with [11C]-Butanol
      Elizabeth J. Li, Javier E. López, Benjamin A. Spencer, Yasser Abdelhafez, Ramsey D. Badawi, Guobao Wang and Simon R. Cherry
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1831-1838; DOI: https://doi.org/10.2967/jnumed.123.265659
  20. Lopez, Oscar L.

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  21. Lopresti, Brian J.

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  22. Lub-de Hooge, Marjolijn N.

    1. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab
      You have access
      Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab
      Philipp Mohr, Joyce van Sluis, Laura Providência, Johannes H. van Snick, Marjolijn N. Lub-de Hooge, Antoon T. Willemsen, Andor W.J.M. Glaudemans, Ronald Boellaard, Adriaan A. Lammertsma, Adrienne H. Brouwers and Charalampos Tsoumpas
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1815-1820; DOI: https://doi.org/10.2967/jnumed.123.265621
  23. Lueckerath, Katharina

    1. Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Open Access
      Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Catherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik and Magnus Dahlbom
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1772-1778; DOI: https://doi.org/10.2967/jnumed.123.265433

M

  1. Ma, Shuaijun

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  2. Makowski, Marcus R.

    1. Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using <sup>18</sup>F-FET PET
      Open Access
      Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18F-FET PET
      Johannes Lohmeier, Helena Radbruch, Winfried Brenner, Bernd Hamm, Anna Tietze and Marcus R. Makowski
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1683-1689; DOI: https://doi.org/10.2967/jnumed.123.265642
  3. Maliha, Peter George

    1. You have access
      Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [68Ga]Ga-FAPI-46 PET–Positive and [18F]FDG PET–Negative
      Peter George Maliha, Abie H. Mendelsohn, Johannes Czernin, Taylor Howard, Jeremie Calais and Masatoshi Hotta
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1839-1840; DOI: https://doi.org/10.2967/jnumed.123.265498
  4. Mason, N. Scott

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  5. Matan, Cristy

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  6. Mathis, Chester A.

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  7. Mavuduru, Ravimohan Suryanarayan

    1. [<sup>177</sup>Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      You have access
      [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Chandan Krushna Das, Ravimohan Suryanarayan Mavuduru, Shikha Goyal, Jaya Shukla and Shrawan Kumar Singh
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1726-1729; DOI: https://doi.org/10.2967/jnumed.123.266141
  8. Meignan, Michel

    1. Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      You have access
      Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas and Caroline Bodet-Milin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1706-1711; DOI: https://doi.org/10.2967/jnumed.123.265871
  9. Mendelsohn, Abie H.

    1. You have access
      Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [68Ga]Ga-FAPI-46 PET–Positive and [18F]FDG PET–Negative
      Peter George Maliha, Abie H. Mendelsohn, Johannes Czernin, Taylor Howard, Jeremie Calais and Masatoshi Hotta
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1839-1840; DOI: https://doi.org/10.2967/jnumed.123.265498
  10. Mennetrey, Clément

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  11. Meyer, Catherine

    1. Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Open Access
      Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Catherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik and Magnus Dahlbom
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1772-1778; DOI: https://doi.org/10.2967/jnumed.123.265433
  12. Minhas, Davneet

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  13. Mittal, Bhagwant Rai

    1. [<sup>177</sup>Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      You have access
      [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Chandan Krushna Das, Ravimohan Suryanarayan Mavuduru, Shikha Goyal, Jaya Shukla and Shrawan Kumar Singh
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1726-1729; DOI: https://doi.org/10.2967/jnumed.123.266141
  14. Mohamad, Bashar

    1. Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      You have access
      Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      Farzaneh Rezazadeh, Nicholas Ramos, Allen-Dexter Saliganan, Najeeb Al-Hallak, Kang Chen, Bashar Mohamad, Wendy N. Wiesend and Nerissa T. Viola
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1806-1814; DOI: https://doi.org/10.2967/jnumed.123.265649
  15. Mohr, Philipp

    1. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab
      You have access
      Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab
      Philipp Mohr, Joyce van Sluis, Laura Providência, Johannes H. van Snick, Marjolijn N. Lub-de Hooge, Antoon T. Willemsen, Andor W.J.M. Glaudemans, Ronald Boellaard, Adriaan A. Lammertsma, Adrienne H. Brouwers and Charalampos Tsoumpas
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1815-1820; DOI: https://doi.org/10.2967/jnumed.123.265621
  16. Morland, David

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  17. Mukherjee, Archana

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  18. Murthy, Vishnu

    1. Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      You have access
      Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1737-1743; DOI: https://doi.org/10.2967/jnumed.122.265155

N

  1. Nardo, Lorenzo

    1. Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Open Access
      Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1821-1830; DOI: https://doi.org/10.2967/jnumed.123.265723
  2. Nguyen, Kathleen

    1. Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      You have access
      Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1737-1743; DOI: https://doi.org/10.2967/jnumed.122.265155
  3. Nonnekens, Julie

    1. You have access
      Second Symposium of the European Working Group on the Radiobiology of Molecular Radionuclide Therapy
      Julie Nonnekens, Bart Cornelissen and Samantha Y.A. Terry; on behalf of the European Working Group on the Radiobiology of Molecular Radiotherapy
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1788-1790; DOI: https://doi.org/10.2967/jnumed.123.265956

O

  1. O’Donoghue, Joseph A.

    1. Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      You have access
      Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      Milan Grkovski, Joseph A. O’Donoghue, Brandon S. Imber, George Andl, Cheng Tu, Daniel Lafontaine, Jazmin Schwartz, Maria Thor, Michael J. Zelefsky, John L. Humm and Lisa Bodei
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1779-1787; DOI: https://doi.org/10.2967/jnumed.123.265763
  2. Omidvari, Negar

    1. Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Open Access
      Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1821-1830; DOI: https://doi.org/10.2967/jnumed.123.265723
  3. Ordonez, Alvaro A.

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  4. Ouvrard, Éric

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584

P

  1. Perrier, Marine

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
  2. Petrik, Milos

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  3. Pocha, Olivia

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  4. Providência, Laura

    1. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab
      You have access
      Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab
      Philipp Mohr, Joyce van Sluis, Laura Providência, Johannes H. van Snick, Marjolijn N. Lub-de Hooge, Antoon T. Willemsen, Andor W.J.M. Glaudemans, Ronald Boellaard, Adriaan A. Lammertsma, Adrienne H. Brouwers and Charalampos Tsoumpas
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1815-1820; DOI: https://doi.org/10.2967/jnumed.123.265621

Q

  1. Qin, Weijun

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  2. Quan, Zhiyong

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001

R

  1. Radbruch, Helena

    1. Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using <sup>18</sup>F-FET PET
      Open Access
      Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18F-FET PET
      Johannes Lohmeier, Helena Radbruch, Winfried Brenner, Bernd Hamm, Anna Tietze and Marcus R. Makowski
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1683-1689; DOI: https://doi.org/10.2967/jnumed.123.265642
  2. Ramming, Andreas

    1. You have access
      FAPI PET/CT Immune-Fibrosis Imaging for New Insights into Rheumatologic Disorders
      Christian Schmidkonz, Armin Atzinger, Andreas Ramming and Torsten Kuwert
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1674-1675; DOI: https://doi.org/10.2967/jnumed.123.266182
  3. Ramos, Nicholas

    1. Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      You have access
      Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      Farzaneh Rezazadeh, Nicholas Ramos, Allen-Dexter Saliganan, Najeeb Al-Hallak, Kang Chen, Bashar Mohamad, Wendy N. Wiesend and Nerissa T. Viola
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1806-1814; DOI: https://doi.org/10.2967/jnumed.123.265649
  4. Rasul, Sazan

    1. Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980
  5. Rauscher, Isabel

    1. Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&amp;T
      You have access
      Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
      Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
  6. Reifegerst, Manuel

    1. Prediction of Response to <sup>177</sup>Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC
      You have access
      Prediction of Response to 177Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC
      Melanie Hohberg, Manuel Reifegerst, Alexander Drzezga, Markus Wild and Matthias Schmidt
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1758-1764; DOI: https://doi.org/10.2967/jnumed.122.264953
  7. Ren, Jing

    1. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
  8. Rettig, Matthew

    1. Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      You have access
      Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1737-1743; DOI: https://doi.org/10.2967/jnumed.122.265155
  9. Rezazadeh, Farzaneh

    1. Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      You have access
      Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      Farzaneh Rezazadeh, Nicholas Ramos, Allen-Dexter Saliganan, Najeeb Al-Hallak, Kang Chen, Bashar Mohamad, Wendy N. Wiesend and Nerissa T. Viola
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1806-1814; DOI: https://doi.org/10.2967/jnumed.123.265649
  10. Rider, Jason H.

    1. Optimized Methods for the Production of High-Purity <sup>203</sup>Pb Using Electroplated Thallium Targets
      You have access
      Optimized Methods for the Production of High-Purity 203Pb Using Electroplated Thallium Targets
      Shefali Saini, Jennifer L. Bartels, Jean-Pierre K. Appiah, Jason H. Rider, Nicholas Baumhover, Michael K. Schultz and Suzanne E. Lapi
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1791-1797; DOI: https://doi.org/10.2967/jnumed.123.265976
  11. Rimawi, Mothaffar

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  12. Röhrich, Manuel

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  13. Rowe, Christopher C.

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  14. Ruszniewski, Philippe

    1. High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584

S

  1. Saini, Shefali

    1. Optimized Methods for the Production of High-Purity <sup>203</sup>Pb Using Electroplated Thallium Targets
      You have access
      Optimized Methods for the Production of High-Purity 203Pb Using Electroplated Thallium Targets
      Shefali Saini, Jennifer L. Bartels, Jean-Pierre K. Appiah, Jason H. Rider, Nicholas Baumhover, Michael K. Schultz and Suzanne E. Lapi
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1791-1797; DOI: https://doi.org/10.2967/jnumed.123.265976
  2. Sakr, Tamer

    1. You have access
      The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
      Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906
  3. Saliganan, Allen-Dexter

    1. Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      You have access
      Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
      Farzaneh Rezazadeh, Nicholas Ramos, Allen-Dexter Saliganan, Najeeb Al-Hallak, Kang Chen, Bashar Mohamad, Wendy N. Wiesend and Nerissa T. Viola
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1806-1814; DOI: https://doi.org/10.2967/jnumed.123.265649
  4. Sartor, Oliver

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  5. Satapathy, Swayamjeet

    1. [<sup>177</sup>Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      You have access
      [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Chandan Krushna Das, Ravimohan Suryanarayan Mavuduru, Shikha Goyal, Jaya Shukla and Shrawan Kumar Singh
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1726-1729; DOI: https://doi.org/10.2967/jnumed.123.266141
  6. Schmidkonz, Christian

    1. You have access
      FAPI PET/CT Immune-Fibrosis Imaging for New Insights into Rheumatologic Disorders
      Christian Schmidkonz, Armin Atzinger, Andreas Ramming and Torsten Kuwert
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1674-1675; DOI: https://doi.org/10.2967/jnumed.123.266182
  7. Schmidt, Matthias

    1. Prediction of Response to <sup>177</sup>Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC
      You have access
      Prediction of Response to 177Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC
      Melanie Hohberg, Manuel Reifegerst, Alexander Drzezga, Markus Wild and Matthias Schmidt
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1758-1764; DOI: https://doi.org/10.2967/jnumed.122.264953
  8. Schroeter, Cathrin

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  9. Schultz, Michael K.

    1. Optimized Methods for the Production of High-Purity <sup>203</sup>Pb Using Electroplated Thallium Targets
      You have access
      Optimized Methods for the Production of High-Purity 203Pb Using Electroplated Thallium Targets
      Shefali Saini, Jennifer L. Bartels, Jean-Pierre K. Appiah, Jason H. Rider, Nicholas Baumhover, Michael K. Schultz and Suzanne E. Lapi
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1791-1797; DOI: https://doi.org/10.2967/jnumed.123.265976
  10. Schwartz, Jazmin

    1. Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      You have access
      Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      Milan Grkovski, Joseph A. O’Donoghue, Brandon S. Imber, George Andl, Cheng Tu, Daniel Lafontaine, Jazmin Schwartz, Maria Thor, Michael J. Zelefsky, John L. Humm and Lisa Bodei
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1779-1787; DOI: https://doi.org/10.2967/jnumed.123.265763
  11. Schwartz, Jennifer

    1. You have access
      Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
      Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
  12. Seban, Romain-David

    1. You have access
      Reply to: HER2-Low Breast Cancer Can Be Visualized by HER2 PET
      Romain-David Seban
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1841-1842; DOI: https://doi.org/10.2967/jnumed.123.266490
  13. Shaaban, C. Elizabeth

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  14. Shariat, Shahrokh

    1. Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980
  15. Shen, John

    1. Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      You have access
      Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1737-1743; DOI: https://doi.org/10.2967/jnumed.122.265155
  16. Shukla, Jaya

    1. [<sup>177</sup>Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      You have access
      [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Chandan Krushna Das, Ravimohan Suryanarayan Mavuduru, Shikha Goyal, Jaya Shukla and Shrawan Kumar Singh
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1726-1729; DOI: https://doi.org/10.2967/jnumed.123.266141
  17. Singh, Shrawan Kumar

    1. [<sup>177</sup>Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      You have access
      [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Chandan Krushna Das, Ravimohan Suryanarayan Mavuduru, Shikha Goyal, Jaya Shukla and Shrawan Kumar Singh
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1726-1729; DOI: https://doi.org/10.2967/jnumed.123.266141
  18. Slavik, Roger

    1. Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Open Access
      Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Catherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik and Magnus Dahlbom
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1772-1778; DOI: https://doi.org/10.2967/jnumed.123.265433
  19. Snitz, Beth

    1. Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941
  20. Soeiro, Paula

    1. Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&amp;T
      You have access
      Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
      Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
  21. Solnes, Lilja B.

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  22. Sood, Ashwani

    1. [<sup>177</sup>Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      You have access
      [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
      Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Chandan Krushna Das, Ravimohan Suryanarayan Mavuduru, Shikha Goyal, Jaya Shukla and Shrawan Kumar Singh
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1726-1729; DOI: https://doi.org/10.2967/jnumed.123.266141
  23. Specht, Jennifer

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  24. Spektor, Anna-Maria

    1. Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046
  25. Spencer, Benjamin A.

    1. Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Open Access
      Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1821-1830; DOI: https://doi.org/10.2967/jnumed.123.265723
    2. Total-Body Perfusion Imaging with [<sup>11</sup>C]-Butanol
      You have access
      Total-Body Perfusion Imaging with [11C]-Butanol
      Elizabeth J. Li, Javier E. López, Benjamin A. Spencer, Yasser Abdelhafez, Ramsey D. Badawi, Guobao Wang and Simon R. Cherry
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1831-1838; DOI: https://doi.org/10.2967/jnumed.123.265659
  26. Stearns, Vered

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  27. Storniolo, Anna Maria

    1. Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
  28. Stuparu, Andreea

    1. Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Open Access
      Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Catherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik and